Effectiveness of an Agentic AI-Based Personalized Dietary Management Algorithm in Health Screening Participants: A Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 200
- 试验地点
- 1
研究概览
简要总结
This randomized controlled trial aims to evaluate the effectiveness of an Agentic AI-based personalized dietary management algorithm among adults undergoing health screening. Participants will be assigned to a control group, a static goal AI intervention group, or an adaptive goal AI intervention group and followed for 12 weeks.
详细描述
This study is a randomized controlled trial designed to evaluate whether an Agentic AI-based personalized dietary management algorithm improves dietary behavior and metabolic health indicators among adults undergoing health screening. Eligible participants will be randomly assigned to one of three groups: standard dietary education and passive dietary recording, AI-generated personalized dietary goals maintained throughout the study period, or adaptive AI-based dietary tracking with dynamic goal adjustment and personalized feedback. Outcomes will be assessed at baseline and after 12 weeks, including dietary evaluation index scores and metabolic health-related clinical indicators.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
盲法说明
This is an open-label study. Participants and investigators will be aware of group assignments.
入排标准
- 年龄范围
- 20 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Adults aged 20 years or older
- •Individuals from the general population who underwent a health examination at the Seoul National University Hospital Healthcare System Gangnam Center
- •Individuals who are capable of independently using a smartphone and operating study-related applications or text messaging functions
- •Individuals without conditions that significantly interfere with standard dietary management, as specified in the
排除标准
- •[Section 9.2 Exclusion Criteria]
- •Exclusion Criteria:
- •Individuals unable to use a smartphone or study-related digital program/application, including those without a smartphone or unable to operate text messaging or application-based functions.
- •End-stage renal disease or patients currently receiving dialysis
- •Active cancer or currently undergoing chemotherapy or radiotherapy
- •Severe heart failure, liver cirrhosis, or hepatic insufficiency accompanied by varices, bleeding, ascites, hepatic encephalopathy, or jaundice
- •Malabsorption disorders such as Crohn's disease or short bowel syndrome
- •Poorly controlled hyperthyroidism or hypothyroidism
- •Diagnosed eating disorders or severe psychiatric disorders
- •Pregnant or breastfeeding women, or women who may become pregnant during study participation.
- •Individuals with recent major weight-related interventions or extreme body weight changes within the past 3 months, including:Bariatric surgery such as gastrectomy or gastric bypass surgery Newly initiated anti-obesity pharmacotherapy (e.g., semaglutide/Wegovy, tirzepatide/Mounjaro)
- •Individuals considered by the investigator to have poor compliance potential or otherwise deemed unsuitable for participation in the clinical study.
研究组 & 干预措施
Control group
Participants receive standard dietary education and perform passive dietary recording during the 12-week study period.
Static goal AI intervention group
Participants receive AI-generated personalized dietary goals that are maintained during the 12-week intervention period.
干预措施: Static AI-based personalized dietary goal setting (Behavioral)
Adaptive goal AI intervention group
Participants receive adaptive AI-based dietary tracking, dynamic goal adjustment, and personalized feedback during the 12-week intervention period.
干预措施: Adaptive AI-based personalized dietary management (Behavioral)
研究者
Su-Yeon Choi
Professor
Seoul National University Hospital